Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Carcinogenesis
PRKCSH contributes to tumorigenesis by selective boosting of IRE1 signaling pathway.
Carcinogenesis
Publisher Correction: PRKCSH contributes to tumorigenesis by selective boosting of IRE1 signaling pathway.
Carcinoma
Glucosidase II beta subunit (GluII?) plays a role in autophagy and apoptosis regulation in lung carcinoma cells in a p53-dependent manner.
Carcinoma
PRKCSH GAG trinucleotide repeat is a mutational target in gastric carcinomas with high-level microsatellite instability.
Cysts
Abnormal hepatocystin caused by truncating PRKCSH mutations leads to autosomal dominant polycystic liver disease.
Cysts
An in vitro model of polycystic liver disease using genome-edited human inducible pluripotent stem cells.
Cysts
Boy with autosomal recessive polycystic kidney and autosomal dominant polycystic liver disease.
Cysts
Chromosomal abnormalities in hepatic cysts point to novel polycystic liver disease genes.
Cysts
Cysts of PRKCSH mutated polycystic liver disease patients lack hepatocystin but express Sec63p.
Cysts
Extensive mutational analysis of PRKCSH and SEC63 broadens the spectrum of polycystic liver disease.
Cysts
Ganab Haploinsufficiency Does Not Cause Polycystic Kidney Disease or Polycystic Liver Disease in Mice.
Cysts
Hepatocystin is Essential for TRPM7 Function During Early Embryogenesis.
Cysts
Hepatocystin is not secreted in cyst fluid of hepatocystin mutant polycystic liver patients.
Cysts
Insights into Autosomal Dominant Polycystic Kidney Disease from Genetic Studies.
Cysts
Liver cyst gene knockout in cholangiocytes inhibits cilium formation and Wnt signaling.
Cysts
Loss of heterozygosity is present in SEC63 germline carriers with polycystic liver disease.
Cysts
Mutations in GANAB, Encoding the Glucosidase II? Subunit, Cause Autosomal-Dominant Polycystic Kidney and Liver Disease.
Cysts
Mutations in PRKCSH cause isolated autosomal dominant polycystic liver disease.
Cysts
PRKCSH Genetic Mutation Was Not Found in Taiwanese Patients with Polycystic Liver Disease.
Cysts
PRKCSH/80K-H, the protein mutated in polycystic liver disease, protects polycystin-2/TRPP2 against HERP-mediated degradation.
Cysts
Secondary, Somatic Mutations Might Promote Cyst Formation in Patients with Autosomal-Dominant Polycystic Liver Disease.
Cysts
The zebrafish as a model to study polycystic liver disease.
Diabetes Complications
DDOST, PRKCSH and LGALS3, which encode AGE-receptors 1, 2 and 3, respectively, are not associated with diabetic nephropathy in type 1 diabetes.
Diabetes Mellitus, Type 1
DDOST, PRKCSH and LGALS3, which encode AGE-receptors 1, 2 and 3, respectively, are not associated with diabetic nephropathy in type 1 diabetes.
Diabetic Nephropathies
DDOST, PRKCSH and LGALS3, which encode AGE-receptors 1, 2 and 3, respectively, are not associated with diabetic nephropathy in type 1 diabetes.
Fibrosarcoma
Blood-based biomarkers for detecting mild osteoarthritis in the human knee.
Kidney Diseases
Novel mutations of PKD genes in Chinese patients suffering from autosomal dominant polycystic kidney disease and seeking assisted reproduction.
Kidney Diseases
Recent advances of mTOR inhibitors use in autosomal dominant polycystic kidney disease: is the road still open?
Liver Diseases
A genetic interaction network of five genes for human polycystic kidney and liver diseases defines polycystin-1 as the central determinant of cyst formation.
Liver Diseases
A noncoding variant in GANAB explains isolated polycystic liver disease (PCLD) in a large family.
Liver Diseases
Abnormal hepatocystin caused by truncating PRKCSH mutations leads to autosomal dominant polycystic liver disease.
Liver Diseases
An interaction between human Sec63 and nucleoredoxin may provide the missing link between the SEC63 gene and polycystic liver disease.
Liver Diseases
Chromosomal abnormalities in hepatic cysts point to novel polycystic liver disease genes.
Liver Diseases
Cysts of PRKCSH mutated polycystic liver disease patients lack hepatocystin but express Sec63p.
Liver Diseases
Expanding the variability of the ADPKD-GANAB clinical phenotype in a family of Italian ancestry.
Liver Diseases
Extensive mutational analysis of PRKCSH and SEC63 broadens the spectrum of polycystic liver disease.
Liver Diseases
Ganab Haploinsufficiency Does Not Cause Polycystic Kidney Disease or Polycystic Liver Disease in Mice.
Liver Diseases
Genetics and mechanisms of hepatic cystogenesis.
Liver Diseases
Germline mutations in PRKCSH are associated with autosomal dominant polycystic liver disease.
Liver Diseases
Hepatocystin is not secreted in cyst fluid of hepatocystin mutant polycystic liver patients.
Liver Diseases
Large Deletions in GANAB and SEC63 Explain 2 Cases of Polycystic Kidney and Liver Disease.
Liver Diseases
Liver cyst gene knockout in cholangiocytes inhibits cilium formation and Wnt signaling.
Liver Diseases
Mutations in GANAB, Encoding the Glucosidase II? Subunit, Cause Autosomal-Dominant Polycystic Kidney and Liver Disease.
Liver Diseases
Mutations in PRKCSH cause isolated autosomal dominant polycystic liver disease.
Liver Diseases
Mutations in SEC63 cause autosomal dominant polycystic liver disease.
Liver Diseases
N-glycosylation determines the abundance of the transient receptor potential channel TRPP2.
Liver Diseases
Novel GANAB variants associated with polycystic liver disease.
Liver Diseases
Polycystic liver disease is a disorder of cotranslational protein processing.
Liver Diseases
PRKCSH Genetic Mutation Was Not Found in Taiwanese Patients with Polycystic Liver Disease.
Liver Diseases
PRKCSH/80K-H, the protein mutated in polycystic liver disease, protects polycystin-2/TRPP2 against HERP-mediated degradation.
Liver Diseases
Secondary and tertiary structure modeling reveals effects of novel mutations in polycystic liver disease genes PRKCSH and SEC63.
Liver Diseases
Secondary, Somatic Mutations Might Promote Cyst Formation in Patients with Autosomal-Dominant Polycystic Liver Disease.
Liver Diseases
Severe Polycystic Liver Disease Is Not Caused by Large Deletions of the PRKCSH Gene.
Liver Diseases
Whole-exome sequencing reveals LRP5 mutations and canonical Wnt signaling associated with hepatic cystogenesis.
Liver Diseases
[Cystic liver diseases. Genetics and cell biology]
Lymphatic Metastasis
Acidic microenvironment plays a key role in human melanoma progression through a sustained exosome mediated transfer of clinically relevant metastatic molecules.
mannosyl-oligosaccharide alpha-1,3-glucosidase deficiency
An in vitro model of polycystic liver disease using genome-edited human inducible pluripotent stem cells.
Migraine Disorders
A 3-Mb region for the familial hemiplegic migraine locus on 19p13.1-p13.2: exclusion of PRKCSH as a candidate gene. Dutch Migraine Genetic Research Group.
Migraine with Aura
A 3-Mb region for the familial hemiplegic migraine locus on 19p13.1-p13.2: exclusion of PRKCSH as a candidate gene. Dutch Migraine Genetic Research Group.
Neoplasm Metastasis
Acidic microenvironment plays a key role in human melanoma progression through a sustained exosome mediated transfer of clinically relevant metastatic molecules.
Neoplasms
A five-mRNA signature associated with post-translational modifications can better predict recurrence and survival in cervical cancer.
Neoplasms
PRKCSH contributes to tumorigenesis by selective boosting of IRE1 signaling pathway.
Polycystic Kidney Diseases
Chromosomal abnormalities in hepatic cysts point to novel polycystic liver disease genes.
Polycystic Kidney Diseases
Expanding the variability of the ADPKD-GANAB clinical phenotype in a family of Italian ancestry.
Polycystic Kidney Diseases
GANAB and PKD1 Variations in a 12 Years Old Female Patient With Early Onset of Autosomal Dominant Polycystic Kidney Disease.
Polycystic Kidney Diseases
Ganab Haploinsufficiency Does Not Cause Polycystic Kidney Disease or Polycystic Liver Disease in Mice.
Polycystic Kidney Diseases
Large Deletions in GANAB and SEC63 Explain 2 Cases of Polycystic Kidney and Liver Disease.
Polycystic Kidney Diseases
Mutational screening of PKD1 and PKD2 in Indian ADPKD patients identified 95 genetic variants.
Polycystic Kidney Diseases
Mutations in GANAB, Encoding the Glucosidase II? Subunit, Cause Autosomal-Dominant Polycystic Kidney and Liver Disease.
Polycystic Kidney Diseases
Mutations in PRKCSH cause isolated autosomal dominant polycystic liver disease.
Polycystic Kidney Diseases
Novel GANAB variants associated with polycystic liver disease.
Polycystic Kidney Diseases
Novel mutations of PKD genes in Chinese patients suffering from autosomal dominant polycystic kidney disease and seeking assisted reproduction.
Polycystic Kidney Diseases
PRKCSH/80K-H, the protein mutated in polycystic liver disease, protects polycystin-2/TRPP2 against HERP-mediated degradation.
Polycystic Kidney Diseases
Recent advances of mTOR inhibitors use in autosomal dominant polycystic kidney disease: is the road still open?
Polycystic Kidney, Autosomal Dominant
Chromosomal abnormalities in hepatic cysts point to novel polycystic liver disease genes.
Polycystic Kidney, Autosomal Dominant
Expanding the variability of the ADPKD-GANAB clinical phenotype in a family of Italian ancestry.
Polycystic Kidney, Autosomal Dominant
GANAB and PKD1 Variations in a 12 Years Old Female Patient With Early Onset of Autosomal Dominant Polycystic Kidney Disease.
Polycystic Kidney, Autosomal Dominant
Ganab Haploinsufficiency Does Not Cause Polycystic Kidney Disease or Polycystic Liver Disease in Mice.
Polycystic Kidney, Autosomal Dominant
Mutational screening of PKD1 and PKD2 in Indian ADPKD patients identified 95 genetic variants.
Polycystic Kidney, Autosomal Dominant
Mutations in GANAB, Encoding the Glucosidase II? Subunit, Cause Autosomal-Dominant Polycystic Kidney and Liver Disease.
Polycystic Kidney, Autosomal Dominant
Novel GANAB variants associated with polycystic liver disease.
Polycystic Kidney, Autosomal Dominant
Novel mutations of PKD genes in Chinese patients suffering from autosomal dominant polycystic kidney disease and seeking assisted reproduction.
Polycystic Kidney, Autosomal Dominant
Polycystic Kidney Disease without an Apparent Family History.
Polycystic Kidney, Autosomal Dominant
Prevalence Estimates of Polycystic Kidney and Liver Disease by Population Sequencing.
Polycystic Kidney, Autosomal Dominant
PRKCSH/80K-H, the protein mutated in polycystic liver disease, protects polycystin-2/TRPP2 against HERP-mediated degradation.
Polycystic Kidney, Autosomal Dominant
Recent advances of mTOR inhibitors use in autosomal dominant polycystic kidney disease: is the road still open?
Polycystic Kidney, Autosomal Dominant
Updated Canadian Expert Consensus on Assessing Risk of Disease Progression and Pharmacological Management of Autosomal Dominant Polycystic Kidney Disease.
Situs Inversus
PRKCSH/80K-H, the protein mutated in polycystic liver disease, protects polycystin-2/TRPP2 against HERP-mediated degradation.
Spinal Cord Injuries
Down-regulating Circular RNA Prkcsh suppresses the inflammatory response after spinal cord injury.
Virus Diseases
Animal models of biliary injury and altered bile acid metabolism.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
3.2.1.207 mannosyl-oligosaccharide alpha-1,3-glucosidase
more
top
The reliability class of the localization prediction ranges from 1 (very reliable) to 5 (not reliable). 
